These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29361335)

  • 1. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
    Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
    Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia.
    Kanza EM; Nyathirombo A; Larbelee JP; Opoku NO; Bakajika DK; Howard HM; Mambandu GL; Nigo MM; Wonyarossi DU; Ngave F; Kennedy KK; Kataliko K; Bolay KM; Attah SK; Olipoh G; Asare S; Mumbere M; Vaillant M; Halleux CM; Kuesel AC
    Parasit Vectors; 2024 Mar; 17(1):137. PubMed ID: 38491528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.
    Awadzi K; Opoku NO; Attah SK; Lazdins-Helds J; Kuesel AC
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2953. PubMed ID: 24968000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection.
    Bakajika D; Kanza EM; Opoku NO; Howard HM; Mambandu GL; Nyathirombo A; Nigo MM; Kennedy KK; Masembe SL; Mumbere M; Kataliko K; Bolay KM; Attah SK; Olipoh G; Asare S; Vaillant M; Halleux CM; Kuesel AC
    PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010079. PubMed ID: 35476631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxidectin: an oral treatment for human onchocerciasis.
    Milton P; Hamley JID; Walker M; Basáñez MG
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1067-1081. PubMed ID: 32715787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
    Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN; Fagbemi BO
    J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
    Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
    Awadzi K; Dadzie KY; Kläger S; Gilles HM
    Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial.
    Hofmann D; Sayasone S; Sengngam K; Chongvilay B; Hattendorf J; Keiser J
    Lancet Infect Dis; 2021 Aug; 21(8):1151-1160. PubMed ID: 33798487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
    Opoku NO; Gyasi ME; Doe F; Lew D; Hong AR; Chithenga S; Fischer PU; King CL; Weil GJ
    Am J Trop Med Hyg; 2021 Nov; 106(2):740-745. PubMed ID: 34844204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
    Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
    Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
    Abegunde AT; Ahuja RM; Okafor NJ
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of moxidectin 2% equine oral gel and ivermectin 2% equine oral paste against Onchocerca cervicalis (Railliet and Henry, 1910) microfilariae in horses with naturally acquired infections in Formosa (Argentina).
    Mancebo OA; Verdi JH; Bulman GM
    Vet Parasitol; 1997 Dec; 73(3-4):243-8. PubMed ID: 9477510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
    Pion SD; Nana-Djeunga HC; Kamgno J; Tendongfor N; Wanji S; Njiokou F; Prichard RK; Boussinesq M
    PLoS Negl Trop Dis; 2013; 7(2):e2084. PubMed ID: 23469307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo.
    Tagboto SK; Townson S
    Ann Trop Med Parasitol; 1996 Oct; 90(5):497-505. PubMed ID: 8915126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
    Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus.
    Remme J; Baker RH; De Sole G; Dadzie KY; Walsh JF; Adams MA; Alley ES; Avissey HS
    Trop Med Parasitol; 1989 Sep; 40(3):367-74. PubMed ID: 2617046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.